Irish Industry Pact Offers Stability And Visibility

Pricing Mechanisms Will Offer Irish Players Certainty For Launch Planning

A four-year agreement reached between Medicines for Ireland and the Irish government offers suppliers visibility and stability thanks to a combination of clear pricing mechanisms as well as the promise of uptake drivers, the off-patent industry association says.

Ireland Handshake Irish Flag
The Irish agreement offers certainty for launch planning • Source: Alexander Makarov / Alamy Stock Photo

A four-year agreement struck between Medicines for Ireland and the Irish government will offer “certainty for launch planning” for players in Ireland’s off-patent market thanks to a combination of clear long-term pricing mechanisms and drivers for generic and biosimilar uptake, the industry association believes.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Generics Bulletin